Clinical Trials Sponsored by Caring Cross

Total 2516 results

Seoul National University Hospital
Green Cross Corporation

Terminated

Influenza Vaccination in Cancer Patients

Cancer

Korea, Republic of
AHS Cancer Control Alberta
Cross Cancer Institute

Withdrawn

Frequency of Portal Images Required to Enhance Quality Assurance for Breast Cancer Patients Treated With Radiotherapy

Breast Cancer
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Quantifying Lung Tumor Movement Under Deep Inspiration Breath Holds

Lung Cancer

Canada
Seoul National University Hospital
Green Cross Corporation

Completed

Efficacy of Shinabro in Hand Osteoarthritis

Hand Osteoarthritis

Korea, Republic of
Green Cross Corporation
Parexel

Completed

A Study to Access Safety, Tolerability, Pharmacokinetics(PK) and Pharmacodynamics(PD) of Orally Administered GCC-4401C in Healthy Volunteers

Healthy Volunteers

United States
Green Cross Corporation
Symyoo

Completed

GCPGC in Chemotherapy-induced Neutropenia

Chemotherapy Induced Neutropenia

Korea, Republic of
Seoul National University Hospital
Green Cross Corporation

Completed

Pharmacokinetics and Pharmacodynamics of a Novel Pegylated Recombinant Human Granulocyte-Colony Stimulating Factor (GCPGC)

Healthy

Korea, Republic of
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Trial of Hypofractionated Radiation Therapy for Glioblastoma

Glioblastoma

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Active, not recruiting

Review of Medical Records of Patients Who Have Been Treated With Lutetium at the Cross Cancer Institute Between January 2010 and April 30, 2014

Neuroendocrine Tumors, NET

Canada
University of Pennsylvania
Blue Cross Blue Shield

Completed

Spending and Outcomes for Complex Medicare Advantage Patients

Kidney Failure, Chronic
AHS Cancer Control Alberta
Cross Cancer Institute

Terminated

An Imaging Study of [18]F-fluoro-3'-Deoxy-3'-L-fluorothymidine ([18]F-FLT) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Who Will be Treated With Gemcitabine or Other Nucleoside Analogs

Pancreatic Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Terminated

A Phase I Dose Escalation Study of Erlotinib in Combination With Theophylline

Non-small Cell Lung Cancer | Advanced Solid Malignancies

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Withdrawn

An Imaging Study in Patients With Thyroid Cancer or Head and Neck Cancer With Pertechnetate Made in a Cyclotron (C-PERT)

Head and Neck Neoplasms | Thyroid Neoplasms
AHS Cancer Control Alberta
Cross Cancer Institute

Unknown

Study to See Whether Breath-Hold Techniques During RT Are Effective in Helping to Improve Sparing of the Heart

Breast Cancer | Adverse Effect of Radiation Therapy

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Unknown

A Study of Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck Cancers

Glioma | Breast Cancer | Head and Neck Cancer | Carcinoma, Squamous Cell | Prostate Cancer | Carcinoma, Non-Small-Cell-Lung

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Phase I/II Study of Fractionated Stereotactic Radiotherapy for Early Stage Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Pulse Sequence Development on 3T Magnetic Resonance Imaging/Spectroscopy

Healthy

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Phase II Trial of Consolidative Thoracic Radiotherapy for Extensive Stage Small Cell Lung Cancer

Extensive Stage Small Cel Lung Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

A Prospective Study of Acute Cardiovascular Effects of First-line Sunitinib in Metastatic Renal Cell Carcinoma Patients (SUnitinib Prospective CardiovasculaR Effect) (SUPER)

Heart Failure | Renal Cell Carcinoma | Hypertension | Cardiotoxicity

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Nutritional Status and Barriers to Dietary Intake in Head and Neck Cancer Patients

Head and Neck Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Mathematical Modeling Analysis of Serum Prostate Specific Antigen After Radiotherapy

Prostate Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Xerostomia in Head and Neck Cancer Patients Receiving Radiation as the Primary Treatment Versus Patients Who Will Not Have Such a Procedure

Head and Neck Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

MVCT Imaging Pilot Study Using Helical Tomotherapy

Cancer, Carcinoma

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Hypofractionated Radiotherapy for Limited Stage Small Cell Lung Cancer

Small Cell Carcinoma | Lung Neoplasm

Canada
Karolinska Institutet
Swedish Red Cross University College

Completed

Coping Effectiveness Training in Patients With Chronic Heart Failure

Heart Failure
Seoul St. Mary's Hospital
Green Cross Corporation

Terminated

The Efficacy and Safety Study of ALbumin Therapy in Acute Ischemic Stroke (ALbumin)

Cerebral Infarction

Korea, Republic of
Suturion AB
Cross Research S.A.; Helsingborgs Hospital

Recruiting

Clinical Performance and Safety of Suture-TOOL

Wound Infection | Incisional Hernia | Laparotomy | Closure Technique

Sweden
AHS Cancer Control Alberta
Cross Cancer Institute

Not yet recruiting

Trial of Combined Radiotherapy and Vertebroplasty for Patients With Painful Metastatic Spinal Lesions

Spinal Metastases

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Recruiting

Unilateral Neck Radiotherapy in Head and Neck Cancer

Head and Neck Neoplasms

Canada
University of Pennsylvania
Independence Blue Cross; CardaHealth

Active, not recruiting

Effect of a Virtually Implemented Cardiac Rehabilitation Program (VIRT-CR)

Heart Failure

United States
University of South Wales
British Red Cross

Withdrawn

A Mental Health Social Prescribing Trial (British Red Cross) (PROSPECT)

Mental Health Wellness 1

United Kingdom
Hellenic Red Cross Hospital
G.Gennimatas General Hospital

Completed

Quality of Life Assessment Between Stroke and Multiple Sclerosis Patients of the Same Age Range (QoLSMS)

Depression | Stroke | Quality of Life | Multiple Sclerosis | Mental Health Disorder

Greece
Seoul National University Hospital
Green Cross Corporation

Unknown

Effect of Polyglycolic Acid Mesh (Neoveil) in Thyroid Cancer Surgery

Thyroid Cancer | Thyroid Gland Carcinoma | Thoracic Duct Leak

Korea, Republic of
AHS Cancer Control Alberta
Cross Cancer Institute

Unknown

A Pilot Study to Evaluate the Feasibility of Combining Submandibular Salivary Gland Tx & IMRT Tomo to Reduce Xerostomia

Head and Neck Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

A Phase I, Open-Labeled, Single-Arm, Dose Escalation, Clinical and Pharmacology Study of Dichloroacetate (DCA) in Patients With Recurrent and/or Metastatic Solid Tumours (DCA)

Neoplasms

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence

Sarcoma | Kidney Neoplasms | Testicular Neoplasms | Multiple Myeloma | Ovarian Neoplasms

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

A Pilot Study of Exercise in Patients With Docetaxel-Based Chemotherapy for Hormone Refractory Prostate Cancer

Prostatic Neoplasms | Neoplasm Metastasis | Palliative Care

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Study of Glutamine as Prophylaxis for Irinotecan Induced Diarrhea

Metastatic Colorectal Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Clinico-pathologic Correlative Study of 3T Magnetic Resonance Spectroscopy in the Localization of Prostate Cancer

Prostate Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Withdrawn

An Initial Feasibility Study to Integrate MRI Based Brachytherapy and CT/MR Fused INRT in Treatment of Advance Cervical Cancer (IMRT)

Locally Advanced Cervical Cancer | Integrated MRI Based RT as Standard of Care
AHS Cancer Control Alberta
Cross Cancer Institute

Terminated

Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Soft Tissue Sarcoma

Sarcoma

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Study to Determine the Prevalence of Osteoporosis in Patients With Advanced Prostate Cancer Treated With Hormonal Manipulation

Prostate Cancer | Osteoporosis

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Optimization of Spectroscopic Imaging Parameters and Procedures for Prostate at 3 Tesla Using an External Probe

Healthy

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Hypofractionated Radiotherapy for Small Cell Lung Cancer

Small Cell Carcinoma | Lung Neoplasm

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

High Field Magnetic Resonance Spectroscopy Imaging for Follow Up of Prostate Cancer Post Brachytherapy Implantation

Prostatic Neoplasm

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Evaluating Taste and Smell Function and Food and Taste Preferences of Head and Neck Cancer Patients During Radiation Therapy/Chemotherapy

Head and Neck Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Withdrawn

A Trial of Glutamine to Prevent Oxaliplatin Neurotoxicity and a Pharmacokinetic Analysis of Oxaliplatin

Colorectal Cancer | Metastasis | Colorectal Tumors | Colorectal Carcinoma | Neoplasms, Colorectal
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Cone Beam CT Scanning in Lung and Bladder Cancer.

Bladder Carcinoma | Small Cell Carcinoma | Lung Neoplasm

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Study of Radiation Dose Intensity Concurrent With Chemotherapy For Limited Stage Small Cell Lung Cancer

Carcinoma, Small Cell

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Magnetic Resonance Spectroscopic Imaging (MRS) and Tumor Perfusion of Human Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide

Glioma | Glioblastoma

Canada

Clinical Trials Sponsored by Caring Cross

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uzbekistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations